TY - JOUR
T1 - Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis
T2 - a cross-sectional analysis of an international multicenter trial
AU - Radtke, Thomas
AU - Kriemler, Susi
AU - Stein, Lothar
AU - Karila, Chantal
AU - Urquhart, Don S
AU - Orenstein, David M.
AU - Lands, Larry C.
AU - Schindler, Christian
AU - Eber, Ernst
AU - Haile, Sarah R.
AU - Hebestreit, Helge
AU - Eber, Ernst
AU - Wagner, Marlies
AU - Ellemunter, Helmut
AU - Alarie, Nancy
AU - Simon, Clotilde
AU - Faucou, Anne
AU - Mely, Laurent
AU - Ravaninjatovo, Bruno
AU - Prevotat, Anne
AU - Hebestreit, Helge
AU - Schaeff, Jonathan
AU - Koerner-Rettberg, Cordula
AU - Hammermann, Jutta
AU - Smaczny, Christina
AU - Held, Inka
AU - Junge, Sibylle
AU - Nitsche, Oliver
AU - Fischer, Rainald
AU - Große-Onnebrink, Jörg
AU - Wesner, Anne
AU - Hector, Andreas
AU - Hebestreit, Alexandra
AU - Radtke, Thomas
AU - Benden, Christian
AU - Casaulta, Carmen
AU - Fischer, Reta
AU - Möller, Alexander
AU - Hulzebos, Erik
AU - Burghard, Marcella
AU - Urquhart, Don S
AU - Blacklock, Sarah
AU - Miller, Debbie
AU - Johnstone, Zoe
AU - Lowman, John D.
N1 - Funding Information:
ACTIVATE-CF is an investigator-initiated trial. The study was supported by Mukoviszidose e.V.; Cystic Fibrosis Switzerland (CFS); Cystic Fibrosis Canada; Vaincre la Mucoviscidose (France); Nederlandse Cystic Fibrosis Stichting; Edinburgh Children's Hospital Charity; The Swiss National Science Foundation; the Cystic Fibrosis Foundation; and Mylan Healthcare GmbH. The international coordination of the project was funded through a Vertex Innovation Award which is an unconditional research grant provided by Vertex Pharmaceuticals (Europe) Limited. The funding bodies had no role in the design of the study, data collection, and in the writing of this manuscript.
Publisher Copyright:
© 2022
PY - 2023/1
Y1 - 2023/1
N2 - Background: Previous studies have reported differences in aerobic exercise capacity, expressed as peak oxygen uptake (VO2peak), between people with and without cystic fibrosis (CF) related diabetes (CFRD). However, none of the studies controlled for the potential influence of physical activity on VO2peak. We investigated associations between CFRD and VO2peak following rigorous control for confounders including objectively measured physical activity. Methods: Baseline data from the international multicenter trial ACTIVATE-CF with participants ≥12 years performing up to 4 h per week of vigorous physical activity were used for this project. Multivariable models were computed to study associations between CFRD and VO2peak (mL.min−1) adjusting for a set of pre-defined covariates: age, sex, weight, forced expiratory volume in 1 s (FEV1), breathing reserve index, Pseudomonas aeruginosa infection, and physical activity (aerobic step counts from pedometry). Variables were selected based on their potential confounding effect on the association between VO2peak and CFRD. Results: Among 117 randomized individuals, 103 (52% female) had a maximal exercise test and were included in the analysis. Participants with (n = 19) and without (n = 84) CFRD did not differ in FEV1, physical activity, nutritional status, and other clinical characteristics. There were also no differences in VO2peak (mL.min−1 or mL.kg−1.min−1 or% predicted). In the final multivariable model, all pre-defined covariates were significant predictors of VO2peak (mL.min−1), however CFRD [coefficient 82.1, 95% CI -69.5 to 233.8, p = 0.28] was not. Conclusions: This study suggests no meaningful differences in VO2peak between people with and without CFRD given comparable levels of physical activity.
AB - Background: Previous studies have reported differences in aerobic exercise capacity, expressed as peak oxygen uptake (VO2peak), between people with and without cystic fibrosis (CF) related diabetes (CFRD). However, none of the studies controlled for the potential influence of physical activity on VO2peak. We investigated associations between CFRD and VO2peak following rigorous control for confounders including objectively measured physical activity. Methods: Baseline data from the international multicenter trial ACTIVATE-CF with participants ≥12 years performing up to 4 h per week of vigorous physical activity were used for this project. Multivariable models were computed to study associations between CFRD and VO2peak (mL.min−1) adjusting for a set of pre-defined covariates: age, sex, weight, forced expiratory volume in 1 s (FEV1), breathing reserve index, Pseudomonas aeruginosa infection, and physical activity (aerobic step counts from pedometry). Variables were selected based on their potential confounding effect on the association between VO2peak and CFRD. Results: Among 117 randomized individuals, 103 (52% female) had a maximal exercise test and were included in the analysis. Participants with (n = 19) and without (n = 84) CFRD did not differ in FEV1, physical activity, nutritional status, and other clinical characteristics. There were also no differences in VO2peak (mL.min−1 or mL.kg−1.min−1 or% predicted). In the final multivariable model, all pre-defined covariates were significant predictors of VO2peak (mL.min−1), however CFRD [coefficient 82.1, 95% CI -69.5 to 233.8, p = 0.28] was not. Conclusions: This study suggests no meaningful differences in VO2peak between people with and without CFRD given comparable levels of physical activity.
KW - Cystic fibrosis related diabetes
KW - Dysglycaemia
KW - Exercise capacity
KW - Peak oxygen uptake
KW - Physical activity
KW - Cystic Fibrosis/complications
KW - Cross-Sectional Studies
KW - Humans
KW - Male
KW - Diabetes Mellitus
KW - Exercise Test
KW - Exercise
KW - Female
UR - http://www.scopus.com/inward/record.url?scp=85133821701&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2022.06.012
DO - 10.1016/j.jcf.2022.06.012
M3 - Article
C2 - 35803884
AN - SCOPUS:85133821701
SN - 1569-1993
VL - 22
SP - 31
EP - 38
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 1
ER -